Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I
The synthetic opioids schedule I placement of butonitazene, flunitazene, and metodesnitazene highlights emerging public health concerns. These substances have high abuse potential and no accepted medical use. Clinicians should stay informed about these…
Recreational Drugs Triple Stroke Risk in Young People, Study Finds
A recent study highlights recreational drugs stroke risk as tripling in young adults. Cannabis and cocaine use significantly elevate stroke risk in this population. Clinicians should screen for recreational drugs stroke risk when assessing young stroke…
College is hard lmao
The endocannabinoid system does regulate stress response, but cramming at 2 AM with THC is still not a peer-reviewed study method. Via r/trees Further Reading Cannabis NewsRecreational drugs triple the risk of stroke in young people, study finds | The…
Megamind peeking
When your patient asks if cannabis can help their nausea and you’re trying to remember if that’s actually supported by the literature. Further Reading Cannabis NewsRecreational drugs triple the risk of stroke in young people, study finds |…
Marijuana Rescheduling: Key Regulatory Updates March 2026
The marijuana rescheduling proposal is a key focus in the March 2026 regulatory updates. This change could impact cannabis clinical practice and research access. Marijuana rescheduling remains central to evolving federal cannabis policy.
Cannabinoid Drug Delivery Breakthroughs in Recent Research
This digest highlights cannabinoid drug delivery breakthroughs alongside key findings on liver disease and adolescent brain health. Advances in delivery technology improve cannabinoid bioavailability and therapeutic potential. Clinicians should consider…
Regulatory Digest: Marijuana Rescheduling and Clinical Research
Marijuana rescheduling clinical research is a pivotal topic in 2026 regulatory updates. This shift could enable expanded clinical trials and evidence-based cannabis therapeutics. Understanding these changes is essential for clinicians and researchers…
Cannabis Pediatric Exposure Toxicity: March 08, 2026 Review
This summary covers cannabis pediatric exposure toxicity reported in recent articles. Acute cannabinoid toxicity in children remains a critical clinical concern. The focus is on ingestion risks, symptoms, and management.
Endocannabinoid System Research: Cannabis PTSD Meta-Analysis
This cannabis PTSD meta-analysis examines trauma-focused treatment outcomes in patients with co-occurring substance use disorders. Findings show trauma-focused therapies remain effective regardless of cannabis use. Clinicians should consider these…
New study reveals surprising benefit of GLP-1s beyond weight loss
A recent study highlights the potential of GLP-1 addiction risk reduction in lowering vulnerability to multiple substances. This research suggests GLP-1 receptor agonists may influence reward pathways independently of weight loss. Clinicians should…
